Board Meeting Announcement for Glaxosmithkline Pharmaceuticals Ltd - Feb 14, 2025

GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 inter alia to consider and approve Un Audited financial results for quarter and nine months ended 31st December 2024 Further to letter dated 15th January 2025, relating to intimation of Board Meeting scheduled to be held on Monday, 10th February 2025 the Board meeting is rescheduled on Friday, 14th February 2025 inter-alia, to approve and take on record the Un-audited financial results for the third quarter & nine months ended 31st December 2024. As per attachment (As per BSE Announcement Dated on 20/01/2025)